Amarin Corp. Plc (AMRN)
13.63
-0.08
(-0.58%)
USD |
NASDAQ |
Sep 04, 16:00
13.58
-0.05
(-0.37%)
After-Hours: 20:00
Amarin Cash and Short Term Investments (Annual) : 302.79M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 302.79M |
| December 31, 2024 | 294.52M |
| December 31, 2023 | 321.18M |
| December 31, 2022 | 309.88M |
| December 31, 2021 | 458.05M |
| December 31, 2020 | 504.85M |
| December 31, 2019 | 648.50M |
| December 31, 2018 | 250.73M |
| December 31, 2017 | 74.24M |
| December 31, 2016 | 99.89M |
| December 31, 2015 | 107.56M |
| December 31, 2014 | 120.14M |
| December 31, 2013 | 192.51M |
| December 31, 2012 | 260.24M |
| Date | Value |
|---|---|
| December 31, 2011 | 116.60M |
| December 31, 2010 | 31.44M |
| December 31, 2009 | 52.26M |
| December 31, 2008 | 14.24M |
| December 31, 2007 | 18.36M |
| December 31, 2006 | 36.81M |
| December 31, 2005 | 33.88M |
| December 31, 2004 | 10.99M |
| December 31, 2003 | 2.102M |
| December 31, 2002 | 24.26M |
| December 31, 2001 | 30.17M |
| December 31, 2000 | 17.05M |
| December 31, 1999 | 1.633M |
| December 31, 1998 | 2.128M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Neurocrine Biosciences, Inc. | 1.480B |
| Alkermes Plc | 1.319B |
| DBV Technologies SA | 194.17M |
| Cellectis SA | 208.66M |
| Akari Therapeutics Plc | 5.263M |